Evolving overdose crisis shakes previously effective treatments

“You can’t inject a horse tranquilizer and think nothing bad is gonna happen” to you, said Ty Sears, 33, a longtime drug user now in recovery.

PCA Rx & Cost Plus Drugs Partner to Transform Drug Pricing Transparency

What You Should Know: – PCA Rx and Cost Plus Drugs, are joining forces to tackle the longstanding issue of opaque and inflated drug pricing

December 18, 2023

Pain, Impairment Linger Months After ECMO for Most

Many extracorporeal membrane oxygenation (ECMO) patients experienced long-term neuropsychiatric symptoms, cognitive impairment, or functional impairment, a meta-analysis found. Fully 41% of ECMO patients had neuropsychiatric

January 12, 2024

Gilead gets a boost from California court in a case over slow-walking an HIV drug

In a boost for Gilead Sciences, the California Supreme Court agreed to review a contentious legal theory that thousands of HIV patients have used in

May 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.